ARDAC Third Phase Study

ARDAC 第三阶段研究

• 批准号: nhmrc : GNT1050583
• 负责人: Dr Elisabeth Hodson
• 金额: $ 181.65万
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2013
• 资助国家: 澳大利亚
• 起止时间: 2013-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/ardac-phase-study/1344517
• 关键词: ARDAC; Third; Phase; Study

Aboriginal Australians are diagnosed with chronic kidney disease at approximately 10 times the rate of non-Aboriginal Australians. Since 2002, the ARDAC Study has examined the early markers of kidney and heart disease in Aboriginal and non-Aboriginal children and adolescents. The study aims to determine if the increased risk of chronic kidney and heart disease seen in Aboriginal adults begins during adolescence and young adulthood as an increased prevalence of chronic disease risk factors.

土著澳大利亚人被诊断为慢性肾脏疾病的比率大约是非土著澳大利亚人的10倍。自2002年以来，ARDAC的研究检查了土著和非土著儿童和青少年肾脏和心脏病的早期标志。这项研究的目的是确定土著成年人患慢性肾脏和心脏病的风险增加是否始于青春期和青年时期，因为慢性病风险因素的患病率增加。